Prostate cancer: epigenetic alterations, risk factors, and therapy

MM Kgatle, AA Kalla, MM Islam, M Sathekge… - Prostate …, 2016 - Wiley Online Library
Prostate cancer (PCa) is the most prevalent urological cancer that affects aging men in
South Africa, and mechanisms underlying prostate tumorigenesis remain elusive. Research …

The complexity of prostate cancer: genomic alterations and heterogeneity

LK Boyd, X Mao, YJ Lu - Nature reviews urology, 2012 - nature.com
Although prostate cancer is the most common malignancy to affect men in the Western
world, the molecular mechanisms underlying its development and progression remain …

The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia

JR Dobosy, JLW Roberts, VX Fu, DF Jarrard - The Journal of urology, 2007 - Elsevier
PURPOSE: Prostate cancer research has focused significant attention on the mutation,
deletion or amplification of the DNA base sequence that encodes critical growth or …

Promoter hypermethylation as a biomarker in prostate adenocarcinoma

JY Park - … risk Assessment, Diagnosis, Treatment, and Prognosis, 2015 - Springer
There is increasing evidence that DNA methylation is a critical source of gene regulation. In
addition, interindividual differences in DNA methylation status in cancer related genes are …

[HTML][HTML] Molecular pathways and targets in prostate cancer

E Shtivelman, TM Beer, CP Evans - Oncotarget, 2014 - ncbi.nlm.nih.gov
Prostate cancer co-opts a unique set of cellular pathways in its initiation and progression.
The heterogeneity of prostate cancers is evident at earlier stages, and has led to rigorous …

Chromatin reprogramming as an adaptation mechanism in advanced prostate cancer

PR Braadland, A Urbanucci - Endocrine-related cancer, 2019 - erc.bioscientifica.com
Tumor evolution is based on the ability to constantly mutate and activate different pathways
under the selective pressure of targeted therapies. Epigenetic alterations including those of …

Prostate cancer as a model system for genetic diversity in tumors

JA Squire, PC Park, M Yoshimoto, J Alami… - Advances in cancer …, 2011 - Elsevier
This chapter will summarize novel understandings of the early molecular events in prostatic
carcinogenesis that may underlie both the genetic and clinical heterogeneity. Areas covered …

[HTML][HTML] Epigenetic regulation of androgen receptor gene expression in human prostate cancers

T Nakayama, M Watanabe, H Suzuki, M Toyota… - Laboratory …, 2000 - Elsevier
Epigenetic mechanisms including DNA methylation and histone deacetylation are thought to
play important roles in gene transcriptional inactivation. Heterogenous expression of …

Molecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targets

B Gurel, T Iwata, CM Koh… - Advances in anatomic …, 2008 - journals.lww.com
Prostatic adenocarcinoma is extremely common in Western nations, representing the
second leading cause of cancer death in American men. The recent application of …

Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease

E LaTulippe, J Satagopan, A Smith, H Scher… - Cancer research, 2002 - AACR
The identification of genes that contribute to the biological basis for clinical heterogeneity
and progression of prostate cancer is critical to accurate classification and appropriate …